Premium
Bengaluru-based pharma contract research company Anthem Biosciences Pvt. Ltd, which hit the billion-dollar valuation mark two years ago after private equity player True North bought minority stake, is now mulling fresh funding as it gears up for an IPO next year, people aware of the development told VCCircle. Founded in 2007 ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
